| __timestamp | Sarepta Therapeutics, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 49315000 | 5078000000 |
| Thursday, January 1, 2015 | 75043000 | 4717000000 |
| Friday, January 1, 2016 | 83749000 | 5096000000 |
| Sunday, January 1, 2017 | 122682000 | 4986000000 |
| Monday, January 1, 2018 | 207761000 | 4214000000 |
| Tuesday, January 1, 2019 | 284812000 | 3806000000 |
| Wednesday, January 1, 2020 | 317875000 | 3671000000 |
| Friday, January 1, 2021 | 282660000 | 3528000000 |
| Saturday, January 1, 2022 | 451421000 | 3445000000 |
| Sunday, January 1, 2023 | 481871000 | 3498000000 |
| Monday, January 1, 2024 | 3702000000 |
Unleashing insights
In the ever-evolving pharmaceutical industry, managing operational costs is crucial for sustaining growth and innovation. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two prominent players: Teva Pharmaceutical Industries Limited and Sarepta Therapeutics, Inc., from 2014 to 2023.
Teva, a global leader in generic medicines, has seen a notable reduction in SG&A expenses, dropping approximately 31% from 2014 to 2023. This decline reflects Teva's strategic efforts to streamline operations amidst challenging market conditions.
Conversely, Sarepta, known for its pioneering work in genetic medicine, experienced a staggering 878% increase in SG&A expenses over the same period. This surge underscores Sarepta's aggressive expansion and investment in research and development.
These contrasting trends highlight the diverse strategies employed by pharmaceutical companies to navigate the complexities of the healthcare landscape.
Cost Management Insights: SG&A Expenses for Amgen Inc. and Teva Pharmaceutical Industries Limited
Who Optimizes SG&A Costs Better? Zoetis Inc. or Sarepta Therapeutics, Inc.
Comparing SG&A Expenses: Takeda Pharmaceutical Company Limited vs Sarepta Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: argenx SE vs Teva Pharmaceutical Industries Limited
Comparing SG&A Expenses: Teva Pharmaceutical Industries Limited vs Ultragenyx Pharmaceutical Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and CRISPR Therapeutics AG
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Teva Pharmaceutical Industries Limited or Supernus Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Insmed Incorporated vs Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. vs Walgreens Boots Alliance, Inc.: SG&A Expense Trends
Sarepta Therapeutics, Inc. or MorphoSys AG: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Sarepta Therapeutics, Inc. or Evotec SE